Day One, 19th February, 2020

07:30 Registration & Coffee

08:20 Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates

08:30

Global Outlook for Biopharma in 2020 Panel Chaired by: Stephanie Léouzon, Partner & Head of Torreya Partners (Europe) LLP Panelists: Ankit Pareek, SVP, Healthcare Investment Banking, Jefferies Chandra Leo, Partner, HBM Partners AG Constantine Chinoporos, CBO, Boston Pharmaceuticals Kieran Rooney, VP, Strategic Alliances & Licensing, Amryt Pharma Plc. Nicholas Franco, EVP & Chief Business Development Officer, Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson Peter Kash, Co-Founder & Vice-Chairman, TargImmune Therapeutics AG

09:15 Keynote Speech - EIT Health e.V.

09:35

Latest Trends in Private Equity & VC Panel Co-Chaired by: Markus Hosang, General Partner, BioMedPartners AG Naveed Siddiqi, Partner, Novo Holdings A/S Panelists: Anja Koenig, Global Head, Novartis Venture Fund Hubert Birner, Managing Partner, TVM Life Science Management GmbH Jeanne Bolger, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc. John Gustofson, Managing Director, AbbVie Ventures Patric Gresko, Head of Division - Innovation & Technology Investments, EIF Tim Haines, Chairman & Managing Partner, Abingworth LLP

10:20 Coffee Break

10:35

Advances in C&G Therapies Panel Co-Chaired by: Alain Vertès, Managing Director, NxR Biotechnologies GmbH Sarah Holland, Global Head of Licensing, Lonza AG Panelists: Michael Maguire, CEO, Avectas Ltd. Rachel Haurwitz, President & CEO, Caribou Biosciences, Inc. Reagan Jarvis, CEO, Anocca AB More TBA...

PR Track A

11:15 Corporate Company Presentation – TBA

11:30

Neuroscience BD&L Panel Co-Chaired by: Christian Thomsen, Global Head of CNS BD&L, Boehringer Ingelheim International GmbH Lubor Gall, SVP, Head of Europe, Locust Walk Panelists: Carlos Buesa, Founder & CEO, Oryzon Genomics S.A. Lynn Durham, Founder & CEO, STALICLA S.A. Mark Altmeyer, President & CEO, Arvelle Therapeutics GmbH Pascal Neuville, CEO, Domain Therapeutics SA Tim Luker, VP, Emerging Technology & Innovation, Corporate BD, Eli Lilly and Company Vanela Bushi, Director, Portfolio Strategy & Transactions, Syneos Health

12:15

Autoimmune & Inflammatory Diseases Panel Co-Chaired by: Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA) Lori Badura, VP, Head of BD Neurology and Immunology - Global BD & Alliance Management, EMD Serono Panelists: Alain Vicari, CEO, Calypso Biotech SA Bernard Bihain, CEO, Genclis SA Hakan Goker, Executive Investment Director, M Ventures Joachim Vogt, Director, Search & Evaluation, Western Europe, AbbVie, Inc. Markus Kalousek, Head of Pharma Search & Evaluation, Global BD&L, Novartis International AG

13:00 Networking Lunch

13:00 Networking Lunch

14:00 PR Track B PR Track C

16:15 Coffee Break

16:30

Oncology Advanced Therapies & Diagnostics Panel Co-Chaired by: David Colpman, Director, Colpman Consulting Ltd. Matthias Müllenbeck, Executive Director & Head Global Licensing & BD Enabling Technologies, Merck KGaA Panelists: Eric Halioua, President & CEO, PDC*line Pharma SA Heinz Lubenau, CEO, VAXIMM GmbH Manuela Maronati, General Manager Europe, Atara Biotherapeutics, Inc. Raphi Levy, CFO, Alpha Tau Medical Ltd. Vishal Doshi, Founder & CEO, AUM Biosciences

PR Track D

17:15

Platform Technologies & Novel Therapeutics Panel Co-Chaired by: Annegret de Baey, Venture Partner, Seventure Partners Julian Bertschinger, Global Head External Strategy DPDS & Therapeutic Platform Innovation, Janssen R&D Panelists: David Urech, CEO, Numab Therapeutics AG Fabian Buller, CBO, Neurimmune AG Frauke Hein, CBO, Adrenomed AG Mai-Britt Zocca, Founder & CEO, IO Biotech ApS Martin Welschof, CEO, BioInvent International AB Yochi Slonim, Co-Founder & CEO, Anima Biotech, Inc.

18:00 Networking Reception

20:00 End of the Networking Reception & Day 1

Day Two, 20th February 2020

08:30 Registration & Coffee

09:00

Pharma DealMakers Roundtable Chaired by: Fintan Walton, CEO, PharmaVentures Ltd. Panelists: Holger Schwarz, Director, Global Head of Search & Evaluation Discovery Technologies, Merck Serono Michael Crowley, Head Business Development for Pharma Research & Early Development, F. Hoffmann-La Roche Ltd. Mike Romanos, CEO, Microbiotica Ltd. Patrick Benz, Sr. Director Alliance Management, The Janssen Pharmaceutical Companies of Johnson & Johnson Sascha Bucher, Head of Global Transactions, Roivant Sciences GmbH

09:50 “Recent Trends in Global Pharma M&A and BD&L” by Nigel Sheail, Global Head of M&A and BD&L, Novartis International AG

10:10

Oncology DealMaking Panel Co-Chaired by: Esteban Pombo Villar, CEO, TargImmune Therapeutics AG Katya Smirnyagina, Partner, Capricorn Venture Partners Panelists: Khatereh Ahmadi, Executive Director, Oncology Search & Evaluation, MSD Michael Huebner, New Venture Lead, Johnson & Johnson Innovation LLC Roberto De Ponti, Head of Corporate New Venture and Strategic Investments, Helsinn Investment Fund Søren Bregenholt, CEO, Macrophage Pharma Ltd. Thilo Schroeder, Partner, Nextech Invest Ltd.

11:00 Coffee Break

11:15

China Partnering & Investment Panel Chaired by: Mirko Scherer, CEO, CoFeS China Ltd. Panelists: Ming Wang, Founder, President & CEO, Phanes Therapeutics, Inc. Olivier Reinhard, VP, Head of Execution for China and Emerging Markets, Sanofi Paul Hermant, Partner, Bird & Bird LLP Piotr Blaszczyk, CEO Fosun Pharma Europe, Fosun Pharmaceutical AG Raven Lin, Vice President of Corporate Development, I-MAB Biopharma Co., Ltd. Yuwen Liu, Founding Partner, BOHE Angel Fund

PR Track E

12:00

Israeli Innovators Panel Chaired by: Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences Panelists: Lior Teitelbaum, Chief Business Officer, FutuRx Ltd. More TBA…

12:45 Networking Lunch

13:30

Early Stage Investor Roundtable Co-Chaired by: Christina Trojel-Hansen, CEO/ Entrepreneur in Residence, Oscine Therapeutics / ARCH Venture Partners Søren Møller, Managing Partner, Novo Seeds, Novo Holdings A/S Panelists: Dani Bach, Partner, NanoDimension Ventures Edward van Wezel, Managing Partner, BioGeneration Ventures Joy Cürten, Business Creation Manager, EIT Health e.V. Michael Altorfer, CEO, Swiss Biotech Association Sten Verland, General Partner, Sunstone Life Science Ventures A/S Thibaut Roulon, Investment Director, Life Sciences Investments, Bpifrance

14:15 Rising Stars: Global Seed Session (Up to 22 Companies) More information TBA

16:00 End of the 13th Annual ELSF Forum